Clinical Study
The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Figure 2
The changes in total Lp-PLA2 mass (a), HDL-Lp-PLA2 (b), and apoB-associated Lp-PLA2 (c) at the baseline and after 8 weeks of intervention. value < 0.05 indicates a significant difference between groups based on the interaction effect shown by the two-way repeated measured ANOVA.
(a) |
(b) |
(c) |